Table 2.
Groups | n | Median Age | Gender (F/M) | Median DAS28 (Baseline) | Median DAS28 (post-treatment) |
---|---|---|---|---|---|
Drug Naïve | 61 | 47 (18–73) | 51/10 | 5.56 (1.88–7.85) | N/A |
TNF-inhibitor | 33 | 51 (25–79) | 31/2 | 5.60 (1.67–8.40) | 5.04 (1.54–7.88) |
Methotrexate | 18 | 45 (18–65) | 12/6 | 5.36 (3.62–7.82) | 3.95 (2.02–6.37) |